Axsome Therapeutics (AXSM) market cap

Market cap today
$7.15B

Axsome Therapeutics (AXSM) has a market cap of $7.15B. At the end of fiscal 2025 (December 31, 2025) its market cap was $9.09B. That is 124.1% higher than the $4.05B of fiscal 2024. Today's figure is 21.3% below the fiscal 2025 year-end. Figures as of 18 Nov 2026, 05:19 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$7.15B
Market cap, fiscal 2025
$9.09B
Change on fiscal 2024
+124.1%
Growth, 5 years
+24.6% a year
Highest on record
$9.09Bfiscal 2025
Lowest on record
$1.42Bfiscal 2021
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Axsome Therapeutics market cap, in more detail

Over the five fiscal years to 2025 the market cap grew at a compound 24.6% a year. Across the 6 fiscal year-ends on record (2020–2025), the highest was $9.09B in fiscal 2025 and the lowest $1.42B in fiscal 2021.

History · 6 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Axsome Therapeutics market cap, year by year

Axsome Therapeutics (AXSM) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$7.15B—$135.95—
2025$9.09B 124.1% up$182.6449.75M
2024$4.05B 12.1% up$84.6147.91M
2023$3.62B 15.3% up$79.5945.43M
2022$3.14B 120.6% up$77.1340.66M
2021$1.42B 53.1% down$37.7837.62M
2020$3.03B—$81.4737.21M
2019——$103.36—
2018——$2.82—
2017——$5.60—
2016——$6.75—
2015——$9.27—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

Market cap at health care companies of similar size

Market cap of Axsome Therapeutics and comparable companies
CompanyMarket cap
Immunovant IMVT$6.87B
Axsome Therapeutics AXSM$7.15B
Chemed CHE$7.09B
Oruka Therapeutics ORKA$6.53B
Arrowhead Pharmaceuticals ARWR$6.08B
MSA Safety MSA$6.66B

Today's market value as the market data feed reports it, each in the currency its shares trade in.

More on AXSM

Axsome Therapeutics, figure by figure

Axsome Therapeutics (AXSM) overview: price, valuation and scorecardAll health care companies by market value

Axsome Therapeutics market cap: questions and answers

What is Axsome Therapeutics's market cap?

Axsome Therapeutics (AXSM) has a market cap of $7.15B. At the end of fiscal 2025 (December 31, 2025) its market cap was $9.09B. That is 124.1% higher than the $4.05B of fiscal 2024.

What is the growth rate of Axsome Therapeutics's market cap?

Over the five fiscal years to 2025 the market cap grew at a compound 24.6% a year.

What are the highest and lowest market cap figures on record for Axsome Therapeutics?

Across the 6 fiscal year-ends on record (2020–2025), the highest was $9.09B in fiscal 2025 and the lowest $1.42B in fiscal 2021.

How is Axsome Therapeutics's market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Axsome Therapeutics (AXSM) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/AXSM/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.